Literature DB >> 19223267

Successful treatment of psychosis with infliximab in a patient with Crohn's disease.

Jens Reimer, Torsten Fink, Michael Bläker, Ingo Schäfer, Christian Otte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223267     DOI: 10.1016/j.schres.2009.01.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  5 in total

Review 1.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

2.  Schizophrenia-like disorder associated with etanercept treatment.

Authors:  Onome Victor Atigari; David Healy
Journal:  BMJ Case Rep       Date:  2014-01-13

Review 3.  Inflammatory bowel disease: an increased risk factor for neurologic complications.

Authors:  Germán Morís
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

4.  Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation.

Authors:  Min-Jung You; Minji Bang; Hyun-Sun Park; Bohyun Yang; Kyu Beom Jang; Jongman Yoo; Dong-Youn Hwang; MinYoung Kim; Borah Kim; Sang-Hyuk Lee; Min-Soo Kwon
Journal:  Transl Psychiatry       Date:  2020-04-27       Impact factor: 6.222

5.  Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database.

Authors:  Eve-Marie Thillard; Sophie Gautier; Evgeniya Babykina; Louise Carton; Ali Amad; Guillaume Bouzillé; Jean-Baptiste Beuscart; Grégoire Ficheur; Emmanuel Chazard
Journal:  Front Pharmacol       Date:  2020-04-22       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.